Clinical Trial Update: Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics [Phase 4]

View source ↗

Summary

This document describes a Phase 4 double-blind, placebo-controlled trial of empagliflozin (JARDIANCE) in individuals with type 2 diabetes and hypertension. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Hypertension, Type II Diabetes | Phase 4 | Status: UNKNOWN